Despite the limitations of our immunohistochemical characterization of HEPH distribution in LUAD and LUSC histotypes, which requires further validation on a broader cohort of patients, the current findings illustrate how complex, multifaced and still poorly understood, is the contribution of iron handling in the pathogenesis of lung cancer. The gene discussed is HEPH; the disease is lung carcinoma.